Your browser doesn't support javascript.
loading
Status of Natural Killer Cell Recovery in Day 21 Bone Marrow after Allogeneic Hematopoietic Stem Cell Transplantation Predicts Clinical Outcome.
Hattori, Norimichi; Saito, Bungo; Sasaki, Yohei; Shimada, Shotaro; Murai, So; Abe, Maasa; Baba, Yuta; Watanuki, Megumi; Fujiwara, Shun; Kawaguchi, Yukiko; Arai, Nana; Kabasawa, Nobuyuki; Tsukamoto, Hiroyuki; Uto, Yui; Ariizumi, Hirotsugu; Yanagisawa, Kouji; Harada, Hiroshi; Nakamaki, Tsuyoshi.
Afiliación
  • Hattori N; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan. Electronic address: nhattor@med.showa-u.ac.jp.
  • Saito B; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Sasaki Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Shimada S; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Murai S; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Abe M; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Baba Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Watanuki M; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Fujiwara S; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Kawaguchi Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Arai N; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Kabasawa N; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Tsukamoto H; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Uto Y; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Ariizumi H; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Yanagisawa K; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Harada H; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
  • Nakamaki T; Division of Hematology, Department of Medicine, Showa University School of Medicine, Tokyo, Japan.
Biol Blood Marrow Transplant ; 24(9): 1841-1847, 2018 09.
Article en En | MEDLINE | ID: mdl-29753837
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante Homólogo / Médula Ósea / Células Asesinas Naturales / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2018 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Trasplante Homólogo / Médula Ósea / Células Asesinas Naturales / Trasplante de Células Madre Hematopoyéticas / Acondicionamiento Pretrasplante Tipo de estudio: Prognostic_studies / Risk_factors_studies Límite: Adolescent / Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Biol Blood Marrow Transplant Asunto de la revista: HEMATOLOGIA / TRANSPLANTE Año: 2018 Tipo del documento: Article